Dora Harangozo

Dora obtained her Master’s degree in Chemistry from ETH Zurich in 2019, where she conducted research on the Synthesis of trypanothione reductase inhibitors in the Diederich group (Chem. Eur. J., 2019) and Templated length-controlled oligomerization in the Wennemers group (Faraday Discuss., 2023). During her master’s studies, she joined the Roche Innovation Center Zurich as an intern, working on antibody purification and quality control. She then transitioned into a Research Associate role, supporting research across multiple therapeutic areas by developing 2D and 3D genetically engineered disease models using advanced genome editing technologies for in vitro and in vivo studies. In May 2025, Dora joined the Corn Lab as a PhD student to investigate how cells sense and respond to genetic perturbations. Her research focuses on uncovering how transcriptional adaptation shapes phenotypic variability and contributes to disease-relevant traits.